Investment Analyst Yathavan Suthaharan discusses why railroads are an attractive infrastructure investment, recent events at Norfolk Southern and what the hype is around Precision Scheduled Railroading (PSR).
The Magellan Infrastructure Fund offers investors an opportunity to invest in a specialised and focused global infrastructure Fund. It aims to achieve attractive risk-adjusted returns over the medium to long term while minimising the risk of permanent capital loss. The Fund has the ASX ticker MICH and comes in an unlisted version with both hedged and unhedged currency management mandates.
Copyright 2023 – Finance News Network
14 Dec 2023 - A snapshot of the stocks on the move, featuring Alkane Resources (ASX:ALK), QX Resources Limited (ASX:QXR) and Buxton Resources (ASX:BUX).
17 Mar 2020 - Cochlear (ASX:COH) today announced that the United States Court of Appeals for the Federal Circuit in Washington, DC has affirmed the US District Court award of US$268 million in patent infringement damages against Cochlear and its US subsidiary Cochlear Americas.
13 Mar 2023 - A snapshot of the stocks on the move featuring Neuren Pharmaceuticals (ASX:NEU), Metro Mining (ASX:MMI) and Meteoric Resources (ASX:MEI).
23 Jan 2020 - The Commonwealth Bank of Australia (ASX:CBA) reports that class action proceedings have been filed by Shine Lawyers against Colonial First State Investments, a subsidiary of CBA.
07 Aug 2020 - Ardent Leisure Group (ASX:ALG) has received financial assistance for its Theme Parks division under the Queensland Government’s Covid 19 Industry Support Package and Queensland Tourism Icons Program 2020.
08 Oct 2019 - SeaLink Travel Group (ASX:SLK) is set to purchase Transit Systems for $635 million in a move to turn the company into one of Australia’s leading multi-modal transport providers.
29 May 2020 - Utilities software solutions provider, Gentrack Group (ASX:GTK) has seen a 78 per cent decline in EBITDA to $4.3 million for the half-year to 31 March 2020, compared to the prior corresponding period.
07 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) today announced that Dr David Cade has joined the Telix executive leadership team in the role of Chief Business Officer and Head of Investor Relations.
